Judge Awards Attys $6M In Fees In Intuniv Antitrust Suit
By Christopher Cole ( December 10, 2020, 8:14 PM EST) -- A Massachusetts federal judge on Wednesday awarded fees exceeding $5.9 million and costs and expenses of about $2.17 million to attorneys representing direct buyers in their claims that pharmaceutical companies Actavis and Shire schemed to stave off a generic form of the attention deficit drug Intuniv....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.